Archive
Proactive news snapshot: ECR Minerals, Corero Network Security, Learning Technologies, Next Fifteen Communications …
A glance at some of the day's highlights from the Proactive Investors newswire
Company
Synairgen PLC
LON:SNG
Synairgen PLC is a UK-based respiratory company focused on drug discovery and the development of SNG001 (inhaled interferon beta) as potentially the first host-targeted, broad-spectrum antiviral treatment delivered directly into the lungs for severe viral lung infections.
149 stories · page 2 of 2
Synairgen, Verona Pharma and why DCF analysis doesn't provide the full picture
A valuation model is only as good as the data plugged in (or omitted)
Investments and investor services
Edenville Energy and Vast Resources shares boosted by project updates
A look at some of the biggest risers and fallers in London.
Archive
Proactive news snapshot: Synairgen, Next Fifteen Communications, Connemara Mining …
A glance at some of the day's highlights from the Proactive Investors newswire
Synairgen’s lead drug well tolerated so far in phase II trial
The trial is in two parts and after the positive interim safety readout, regulators have given the green light for the second stage to go ahead
Investments and investor services
FTSE 100 closes firmly higher as OPEC agrees to lift output
FTSE 100 closed over 125 points higher at 7,682, while FTSE 250 also gained ground, up 280 points to 21,009
Archive
Proactive news snapshot: Synairgen, Vast Resources, Amryt Pharma …
A glance at some of the day's highlights from the Proactive Investors newswire
Vernalis shares fall as the firm puts itself up for sale, CEO and CFO to depart in September
A look at some of the biggest risers and fallers in London on Thursday
Synairgen primed for a successful year
Chairman Simon Shaw said: "Synairgen ended 2017 in a strong position"
Investments and investor services
FTSE 100 closes higher as Dow Jones climbs after host of data
Britain's blue chip index closed up around seven points, or 0.10%, at 7,139..
Archive
Proactive news snapshot: Touchstone Exploration, Highlands Natural Resources, Anglo Pacific Group, Next 15 Communications …
A glance at some of the day's highlights from the Proactive Investors newswire
Gattaca drops as boss steps down with immediate effect, dividend cover doubled
A look at some of the biggest risers and fallers in the London market on Wednesday
Synairgen says first phase II clinical trial patients have been dosed
Researchers are investigating whether the inhaled interferon beta treatment is able to protect sufferers of chronic obstructive pulmonary disease from the exacerbating effects of illnesses such as flu and the common cold
FTSE 100 closes strongly higher as markets stabilise
The UK blue chip index closed up 138 at 7,279 - above the day’s peak of 7,255.
Synairgen 's new fibrosis collaboration terms will free it to work in other areas
The new terms give it the opportunity to benefit from a partnership across a whole range of fibrosis-focused treatments
Archive
Proactive news snapshot: Synairgen, Iofina, Atlantis Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Scancell Holdings soars after "stunning endorsement" of its ImmunoBody platform
Cancer Research UK was immensely impressed with the company and its technology
Synairgen shoots higher on new terms for fibrosis collaboration
Synairgen will retain a 17% interest in any partnership across all fibrotic indications
Pharmaxis takes full control of collaboration on LOXL2 inhibitors and expands scientific program
The program scope has been doubled to encompass two lead candidates.
Archive
Proactive news snapshot: Ergomed , PCF Group, Synairgen …
A glance at some of the day's highlights from the Proactive Investors newswire
Imaginatik lifted by contract win with US investment management company
"We continue to believe that in order for an organisation to build and sustain a business-critical innovation ethos and competency, technology and consultancy need to be implemented in a joined-up way," said Imaginatik
SynairGen to target COPD with inhaled interferon beta treatment
"A COPD programme is now both highly attractive and economically viable"
Archive
It's back to the future for the "Bombed Out" portfolio as NCC returns - again
As one might expect, we'd be better off buying and holding NCC and Rosslyn rather than buying, selling and then buying them back
Archive
Bombed Out portfolio likes the sound of Sound Energy
After a longish break working on the Proactive US site (and then working on his tan), John Harrington is back with a fresh batch of momentum stocks
Archive
Small caps movers: Stagnant UK economy starting to take its toll on some juniors
A look back at some of the more interesting stories on the junior market this week...
Archive
Proactive news snapshot: Synairgen, Silence Therapeutics, LoopUp Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Lots of potential for Synairgen in fibrosis, suggests broker finncap
A Phase I clinical trial is to start later this year for the LOXL-2 inhibitor
Cyber security firm Shearwater soars as chairman increases holding
Sports Direct, Barratt Developments, Ryanair and EasyJet were among Wednesday's early market movers.
Synairgen reports strong interest in new fibrosis treatment ahead of Phase I trial
PXS-5382A, an inhibitor that aids breathing in patients by targeting the LOXL2 enzyme, is being developed with Australian firm Pharmaxis.
Archive
Proactive news round-up: Nasstar, Redx Pharma, Keywords Studios...
A glance at some of the stories on the Proactive newswire...
BP ticks higher as shareholders back CEO's reduced pay at AGM
A look at some of the biggest London-listed risers and fallers today
Synairgen pleased with the progress made with the LOXL2 programme
The company is pleased with the progress made with the LOXL2 programme and clearly is not giving up on its IFN-beta candidate
FTSE 100 closes lower as Trump fears grow; Dow Jones crashes
The UK blue chip index closed down 18.56 points at 7,503
Archive
Small cap movers: PhotonStar shines out on internet-of-things platforms roll-out to student accomodation
A look back at some of the week's more interesting stories from those on the junior market
Herencia Resources and Afarak gain, shares in Turbo Power Systems head south
Herencia Resources is a high riser among London's small caps today as it prepares a drill plan to enhance its copper projects
Synairgen believes interferon beta candidate has potential
The company, which developed and out-licensed AZD9412, believes the interferon beta candidate has potential.
Advanced Oncotherapy rallies on funding update
Some of the largest rises and falls in London at 10.00am: SynairGen, BOS Global, Angus Energy
Synairgen eyes lung fibrosis trial after encouraging lab results
IPF causes a build-up of scar tissue, which damages the structure of the lung and affects normal uptake of oxygen into the blood.
FTSE 100 ends higher as BT declares Openreach plans, US jobs gain
FTSE 100 stocks ended higher on Friday, led by telecoms behemoth BT after confirming it would separate Openreach
Proactive news summary – Mirada, Tissue Regenix, Synairgen and Vast Resources
A selection of the day's significant news stories from the junior AIM market
Risers & Fallers: Petrel rallies on work application in Ghana
Largest share price rises and falls in London at 4.00pm
AstraZeneca likely to adapt clinical trial of Synairgen drug
Hard-to-treat cases of asthma, known as severe exacerbations, tend to be caused by the common cold and flu. Unexpectedly, colds did not cause as many of these exacerbations as researchers predicted.
High profile financier Leonard Licht invests in Synairgen
Now a private investor, Leonard Licht has acquired 2.775mln shares or 3.04%.
Synairgen PLC and why the market is not the best arbiter of value
If the market worked as perfectly as its more rabid advocates insist, we wouldn’t have attractive anomalies such as Synairgen..
Synairgen makes progress with lung drug
Lung drug developer says tests showed success in treating idiopathic pulmonary fibrosis
Investments and investor services
Risers & Fallers: Motive Television, XLMedia, ECR Minerals, Kimberly Enterprises, Spire, Halfords
Below are the main news-driven share price movements at 4pm.
Risers & Fallers: SABMiller, Styles & Wood, Dillistone, Cello Group, Synairgen and Quadrise Fuels
Below are the main news-driven share price movements at 12.30pm.